Identification of a contiguous 6-residue determinant in the MHV receptor that controls the level of virion binding to cells

Virology

Volumn 229, Issue 2, 1997, Pages 336-348

  Rao, Pasupuleti V ^a   Kumari, Suman ^a   Gallagher, Thomas M ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; MEMBRANE RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CELL INVASION; CONTROLLED STUDY; CORONAVIRUS; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION;

CORONAVIRUS; MURINAE; MURINE HEPATITIS VIRUS; VACCINIA; VACCINIA VIRUS;

EID: 0031575821     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8446     Document Type: Article

References (54)

1. A. Aiyar, J. Leis, 1993, Modification of the megaprimer method of PCR mutagenesis: Improved amplification of the final product, 14, 366, 368.
2. Aoki J., Koike S., Ise I., Yoshida Y. S., Nomoto A. Amino acid residues on human poliovirus receptor involved in interaction with poliovirus. J. Biol. Chem. 269:1994;8431-8438.
3. Barthold S. W. Host age and genotypic effects on enterotropic mouse hepatitis virus infection. Lab. Anim. Sci. 37:1987;36-40.
4. Barthold S. W., Beck D. S., Smith A. L. Mouse hepatitis virus nasoencephalopathy is dependent upon virus strain and host genotype. Arch. Virol. 91:1986;247-256.
5. Bates P. A., Luo J., Sternberg M. J. E. A predicted three-dimensional structure of the carcinoembryonic antigen (CEA). FEBS Lett. 301:1992;207-214.
6. Bos E. C. W., Heijnen L., Luytjes W., Spaan W. J. M. Mutational analysis of the murine coronavirus spike protein: Effect on cell-to-cell fusion. Virology. 214:1995;453-463.
7. Boyle J. F., Weismiller D. G., Homes K. V. Genetic resistance to mouse hepatitis virus correlates with absence of virus-binding activity on target tissues. J. Virol. 61:1987;185-189.
8. Broder C. C., Kennedy P. E., Michaels F., Berger E. A. Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors. Gene. 142:1994;167-174.
9. Chen D. S., Asanaka M., Yokomori K., Wang F.-I., Hwang S. B., Li H. P., Lai M. M. C. A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virus. Proc. Natl. Acad. Sci. USA. 92:1995;12095-12099.
10. Chen W., Baric R. S. Molecular anatomy of mouse hepatitis virus persistence: Coevolution of increased host cell resistance and virus virulence. J. Virol. 70:1996;3947-3960.
11. Choe H. R., Sodroski J. Contribution of charged amino acids in the CDR2 region of CD4 to HIV-1 gp120 binding. J. Acquired Immune Defic. Syndr. 5:1992;204-210.
12. Collins A. R., Knobler R. L., Powell H., Buchmeier M. J. Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology. 119:1982;358-371.
13. Compton S. R. Enterotropic strains of mouse coronavirus differ in their use of murine carcinoembryonic antigen-related glycoprotein receptors. Virology. 203:1994;197-201.
14. Dveksler G. S., Pensiero M. N., Cardellichio C. B., Williams R. K., Jiang G.-S., Holmes K. V., Dieffenbach C. W. Cloning of the mouse hepatitis virus (MHV) receptor: Expression in human and hamster cell lines confers susceptibility to MHV. J. Virol. 65:1991;6881-6891.
15. Dveksler G. S., Dieffenbach C. W., Cardellichio C. B., McCuaig K., Pensiero M. N., Jiang G.-S., Beauchemin N., Holmes K. V. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. J. Virol. 67:1993a;1-8.
16. Dveksler G. S., Pensiero M. N., Dieffenbach C. W., Cardellichio C. B., Basile A. A., Elia P. E., Holmes K. V. Mouse hepatitis virus strain A59 and blocking antireceptor monoclonal antibody bind to the N-terminal domain of cellular receptor. Proc. Natl. Acad. Sci. USA. 90:1993b;1716-1720.
17. Dveksler G. S., Basile A. A., Cardellichio C. B., Holmes K. V. Mouse hepatitis virus receptor activities of an MHVR/mph chimera and MHVR mutants lacking N-linked glycosylation of the N-terminal domain. J. Virol. 69:1995;543-546.
18. Elroy-Stein O., Moss B. Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells. Proc. Natl. Acad. Sci. USA. 87:1990;6743-6747.
19. Falkner F. G., Moss B. Escherichia coli. J. Virol. 62:1988;1849-1854.
20. Felgner P. L., Gadek T. R., Holm M., Roman R., Chan H. W., Wenz M., Northrop J. P., Ringold G. M., Danielsen M. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA. 84:1987;7413-7417.
21. Fuerst T. R., Niles E. G., Studier F. W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 83:1986;8122-8126.
22. Gallagher T. M., Buchmeier M. J., Perlman S. Cell receptor-independent infection by a neurotropic murine coronavirus. Virology. 191:1992;517-522.
23. Gallagher T. M. Murine coronavirus membrane fusion is blocked by modification of thiols buried within the spike protein. J. Virol. 70:1996;4683-4690.
24. Gallagher T. M. A role for naturally occurring variation of the murine coronavirus spike protein in stabilizing association with the cellular receptor. J. Virol. 1997.
25. Gombold J. L., Hingley S. T., Weiss S. R. Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. J. Virol. 67:1993;4504-4512.
26. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA. 89:1992;5547-5551.
27. Harrison S. C. CD4: The receptor for HIV. Cellular Receptors for Animal Viruses. 1994;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 33-48.
28. Hingley S. T., Gombold J. L., Lavi E., Weiss S. R. MHV-A59 fusion mutants are attenuated and display altered hepatotropism. Virology. 200:1994;1-10.
29. Hirano N., Murakami T., Fujiwara K., Matsumoto M. Utility of mouse cell line DBT for propagation and assay of mouse hepatitis virus. Jpn. J. Exp. Med. 48:1978;71-75.
30. James W., Weiss R. A., Simon J. H. M. The receptor for HIV: Dissection of CD4 and studies on putative accessory factors. Littman D. R. The CD4 Molecule. 1996;Springer-Verlag, Berlin/Heidelberg.
31. Kawasaki E. S. Amplification of RNA. Innis M. A., Gelfand D. H., Sninsky J. J., White T. J. PCR Protocols. 1990;21-27 Academic Press, San Diego.
32. Lavi E., Gilden D. H., Highkin M. K., Weiss S. R. The organ tropism of mouse hepatitis virus A59 in mice is dependent on dose and route of inoculation. Lab. Anim. Sci. 36:1986;130-135.
33. Lifson J. D., Hwang K. M., Nara P. L., Fraser B., Padgett M., Dunlop N. M., Eiden L. E. Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity. Science. 241:1988;712-716.
34. MacGregor G. R., Nolan G. P., Fiering S., Roederer M., Herzenberg L. Use ofE. coli. Murray E. B., Walker J. M. Gene Expression in Vivo, Methods in Molecular Biology. 1989;Humana Press, Cliffon.
35. Makino S., Taguchi F., Hirano N., Fujiwara K. Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain. Virology. 139:1984;138-151.
36. McCuaig K., Rosenberg M., Nedellec P., Turbide C., Beauchemin N. Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. Gene. 127:1993;173-183.
37. Moebius U., Clayton L. K., Abraham S., Harrison S. C., Reinherz E. L. The HIV gp120 binding site on CD4: Delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high resolution CD4 atomic structure. J. Exp. Med. 176:1992;507-517.
38. Morrison M. E., He Y.-J., Wien M. W., Hogle J. M., Racaniello V. R. Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication. J. Virol. 68:1994;2578-2588.
39. Moss B., Elroy-Stein O., Mizukami T., Alexander W. A., Fuerst T. R. New mammalian expression vectors. Nature. 348:1990;91-92.
40. Nash T. C., Buchmeier M. J. Spike glycoprotein-mediated fusion in biliary glycoprotein-independent cell-associated spread of mouse hepatitis virus infection. Virology. 223:1996;68-78.
41. Nedellec P., Dveksler G. S., Daniels E., Turbide C., Chow B., Basile A. A., Holmes K. V., Beauchemin N. Bgp2, a new member of the carcinoembryonic antigen-related gene family, encodes an alternative receptor for mouse hepatitis viruses. J. Virol. 68:1994;4525-4537.
42. Nussbaum O., Broder C. C., Berger E. A. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J. Virol. 68:1994;5411-5422.
43. Nussbaum O., Broder C. C., Moss B., Stern L. B., Rozenblatt S., Berger E. A. Functional and structural interactions between measles virus hemagglutinin and CD46. J. Virol. 69:1995;3341-3349.
44. Robb J. A., Bond C. W. Pathogenic murine coronaviruses. I. Characterization of biological behavior in vitro and virus-specific intracellular RNA of strongly neurotropic JHMV and weakly neurotropic A59V viruses. Virology. 94:1979;352-370.
45. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
46. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
47. Scharf S. J. Cloning with PCR. Innis M. A., Gelfand D. H., Sninsky J. J., White T. J. PCR Protocols. 1990;84-91 Academic Press, San Diego.
48. Siddell S. G. The coronaviridae: An introduction. Siddell S. G. The Coronaviridae. 1995;1-10 Plenum Press, New York.
49. Sturman L. S., Takemoto K. K. Enhanced growth of a murine coronavirus in transformed mouse cells. Infect. Immun. 6:1972;501-507.
50. Truneh A., Buck D., Cassatt D. R., Juszczak R., Kassis S., Ryu S.-E., Healey D., Sweet R., Sattentau Q. A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion. J. Biol. Chem. 266:1991;5942-5948.
51. Wilson G. A. R., Dales S. In vivo and in vitro models of demyelinating disease: Efficiency of virus spread and formation of infectious centers among glial cells is genetically determined by the murine host. J. Virol. 62:1988;3371-3377.
52. Yokomori K., Lai M. M. C. Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. J. Virol. 66:1992a;6194-6199.
53. Yokomori K., Lai M. M. C. The receptor for mouse hepatitis virus in the resistant mouse strain SJL is functional: Implications for the requirement of a second factor for viral infection. J. Virol. 66:1992b;6931-6938.
54. Yokomori K., Asanaka M., Stohlman S. A., Lai M. M. C. A spike protein-dependent cellular factor other than the viral receptor is required for mouse hepatitis virus entry. Virology. 196:1993;45-56.